Alle verbonden artikelen

Will Testicular Germ Cell Tumors Remain Untargetable?

Auteurs : Aoun F, Kourie HR, Albisinni S, Roumeguère T
Jaar : 2016
Journal : Target Oncol
Volume : 11(6)
Pagina's : 711-21

Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.

Auteurs : Antoine C, Ameye L, Paesmans M, de Azambuja E, Rozenberg S
Jaar : 2016
Journal : Maturitas
Volume : 84
Pagina's : 81-8

70-Gene Signature in Early-Stage Breast Cancer.

Auteurs : van’t Veer LJ, Rutgers EJT, Piccart-Gebhart M
Jaar : 2016
Journal : N Engl J Med
Volume : 375
Pagina's : 2200-2201

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane.

Auteurs : Kaufman PA, Awada A, Twelves C, Yelle L, Perez EA, Velikova G, Olivo MS, He Y, Dutcus CE, Cortes J
Jaar : 2015
Journal : J. Clin. Oncol.
Volume : 33(6)
Pagina's : 594-601

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.

Auteurs : Zardavas D, Fouad TM, Piccart-Gebhart M
Jaar : 2015
Journal : Breast
Volume : 24 Suppl 2
Pagina's : S143-8

Clinical management of breast cancer heterogeneity.

Auteurs : Zardavas D, Irrthum A, Swanton C, Piccart-Gebhart M
Jaar : 2015
Journal : Nat Rev Clin Oncol
Volume : 12(7)
Pagina's : 381-94

Aromatase inhibitors in male breast cancer: a pooled analysis.

Auteurs : Zagouri F, Sergentanis TN, Azim HA, Chrysikos D, Dimopoulos MA, Psaltopoulou T
Jaar : 2015
Journal : Breast Cancer Res. Treat.
Volume : 151(1)
Pagina's : 141-7

Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome.

Auteurs : Goldrat O, Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard O, Demeestere I, Azim HA
Jaar : 2015
Journal : Eur. J. Cancer
Volume : 51(12)
Pagina's : 1490-6

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.

Auteurs : Strasser-Weippl K, Horick N, Smith IE, O Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
Jaar : 2015
Journal : Breast Cancer Res
Volume : 17(1)
Pagina's : 56

Harmonization of the evaluation of tumor infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs-working group 2014.

Auteurs : Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehne FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S
Jaar : 2015
Journal : Ann Oncol
Volume : 26(2)
Pagina's : 259-71

Exploring the safety of chemotherapy for treating breast cancer during pregnancy.

Auteurs : Lambertini M, Kamal NS, Peccatori FA, Del Mastro L, Azim HA
Jaar : 2015
Journal : Expert Opin Drug Saf
Volume : 14(9)
Pagina's : 1395-408

Uncovering the genomic heterogeneity of multifocal breast cancer.

Auteurs : Desmedt C, Fumagalli D, Pietri E, Zoppoli G, Brown D, Nik-Zainal S, Gundem G, Rothé F, Majjaj S, Garuti A, Carminati E, Loi S, Van Brussel T, Boeckx B, Maetens M, Mudie L, Vincent D, Kheddoumi N, Serra L, Massa I, Ballestrero A, Amadori D, Salgado R, de Wind A, Lambrechts D, Piccart-Gebhart M, Larsimont D, Campbell PJ, Sotiriou C
Jaar : 2015
Journal : J. Pathol.
Volume : 236(4)
Pagina's : 457-66

Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development.

Auteurs : Stahel R, Bogaerts J, Ciardiello F, De Ruysscher D, Dubsky P, Ducreux M, Finn S, Laurent-Puig P, Peters S, Piccart-Gebhart M, Smit E, Sotiriou C, Tejpar S, van Cutsem E, Tabernero J
Jaar : 2015
Journal : Cancer Treat Rev
Volume : 41(2)
Pagina's : 129-135

The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.

Auteurs : Hendlisz A, Deleporte A, Delaunoit T, Maréchal R, Peeters M, Holbrechts S, Van den Eynde M, Houbiers G, Filleul B, Van Laethem JL, Ceyssens S, Barbuto AM, Lhommel R, Demolin G, Garcia C, El Mansy H, Ameye L, Moreau M, Guiot T, Paesmans M, Piccart-Gebhart M, Flamen P
Jaar : 2015
Journal : PLoS One
Volume : 10
Pagina's : e0138341

Disappearance of Upper Urinary Tract Urothelial Carcinoma after Treatment of a Borderline Brenner Tumor: Case Report and Literature Review.

Auteurs : Aoun F, Kourie HR, Sirtaine N, Hawaux E
Jaar : 2015
Journal : Oncol Res Treat
Volume : 38(7-8)
Pagina's : 379-81

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

Auteurs : Bartlett JM, McConkey CC, Munro AF, Desmedt C, Dunn JA, Larsimont D, O Malley FP, Cameron DA, Earl HM, Poole CJ, Shepherd LE, Cardoso F, Jensen MB, Caldas C, Twelves CJ, Rea DW, Ejlertsen B, Di Leo A, Pritchard KI
Jaar : 2015
Journal : J. Clin. Oncol.
Volume : 33(15)
Pagina's : 1680-7

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers.

Auteurs : Denkert C, Von Minckwitz G, Brase JC, Sinn BV, Gade S, Kronenwett R, Pfitzner BM, Salat C, Loi S, Schmitt WD, Schem C, Fisch K, Darb-Esfahani S, Mehta K, Sotiriou C, Wienert S, Klare P, André F, Klauschen F, Blohmer J, Krappmann K, Schmidt M, Tesch H, Kümmel S, Sinn P, Jackisch C, Dietel M, Reimer T, Untch M, Loibl S
Jaar : 2015
Journal : J. Clin. Oncol.
Volume : 33(9)
Pagina's : 983-91

Evolution In the therapeutic strategy of localized resectable pancreatic ductal adenocarcinoma.

Auteurs : Van Daele D, Puleo F, Dumont R, Polus M, Loly C, Martinive P, Meunier P, Collignon J, Hendlisz A, Maréchal R, Louis E, Van Laethem JL
Jaar : 2015
Journal : Rev Med Suisse
Volume : 11
Pagina's : 1543-8

St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists.

Auteurs : Ignatiadis M, Buyse M, Sotiriou C
Jaar : 2015
Journal : Ann Oncol
Volume : 26(8)
Pagina's : 1519-20

Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients.

Auteurs : Fouad TM, de Azambuja E, Azim HA
Jaar : 2015
Journal : Ann Oncol
Volume : 26(7)
Pagina's : 1511